EQNCX
Price
$22.97
Change
-$0.11 (-0.48%)
Updated
Aug 15 closing price
Net Assets
664.84M
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

EQNCX vs VVIAX

Header iconEQNCX vs VVIAX Comparison
Open Charts EQNCX vs VVIAXBanner chart's image
MFS Equity Income C
Price$22.97
Change-$0.11 (-0.48%)
VolumeN/A
Net Assets664.84M
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
EQNCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EQNCX vs. VVIAX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNCX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. EQNCX (665M). VVIAX pays higher dividends than EQNCX: VVIAX (2.18) vs EQNCX (1.21). EQNCX was incepted earlier than VVIAX: EQNCX (13 years) vs VVIAX (25 years). EQNCX (1.70) is less costly to investors than VVIAX (0.05). EQNCX is a more actively managed with annual turnover of: 45.00 vs. VVIAX (9.00). EQNCX has a lower initial minimum investment than VVIAX: EQNCX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 8.04 vs. EQNCX (6.72). VVIAX return over 5 years is better than : 68.75 vs. EQNCX (50.90).
EQNCXVVIAXEQNCX / VVIAX
Total Expense Ratio1.640.053,280%
Annual Report Gross Expense Ratio1.700.053,400%
Fund Existence13 years25 years-
Gain YTD9.9836.653150%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets665M196B0%
Annual Yield % from dividends1.212.1856%
Returns for 1 year6.728.0484%
Returns for 3 years21.8026.0984%
Returns for 5 years50.9068.7574%
Returns for 10 years84.65114.8874%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CXW20.820.36
+1.76%
CoreCivic
NBIX132.901.59
+1.21%
Neurocrine Biosciences
ZENV1.640.01
+0.49%
Zenvia
ATYR4.90-0.09
-1.80%
aTyr Pharma Inc
WNW1.69-0.05
-2.80%
Meiwu Technology Company Limited